TriviumVet Secures FDA Conditional Approval for First Treatment for Feline Cardiac Disease
TriviumVet’s felycin®-CA1 has been granted conditional approval by the U.S. Food and Drug Administration (FDA) marking a significant milestone for the Waterford company and in feline cardiac care. Read more

